General Resources / Legal Resources / Medical Resources / Briefing Papers / State Activity    
Hospital Closures / Preventable Tragedies / Press Room / Search Our Site / Home


Treatment Advocacy Center

STATEMENT

By Executive Director, Mary T. Zdanowicz, Esq.


FOR IMMEDIATE RELEASE
October 21, 1998

CONTACT:

703 294 6008 or [email protected]

Suicide Prevention Strategy "Long Overdue"
Says Treatment Advocacy Center

Urges Surgeon General to Hold States Accountable for Americans
Languishing with Untreated Brain Disorders

The Treatment Advocacy Center applauds Surgeon General David Satcher for developing a national suicide prevention strategy that includes reducing barriers to treatment for those suffering from severe mental illness. The Surgeon General identified those most at risk to die from suicide to be individuals with untreated brain disorders.

An estimated 4 million Americans today suffer from the severest forms of brain disorders, schizophrenia and manic-depressive illness. A startling 50 percent of these individuals, or 2 million people, are not receiving treatment on any given day.

Suicide is the number one cause of premature death among people with untreated schizophrenia, with an estimated 10 percent to 13 percent killing themselves. Suicide is even more pervasive in individuals with untreated manic-depressive illness, with 15 percent to 17 percent taking their own lives. The extreme depression and psychoses that result due to lack of treatment are the usual causes of suicide. These suicide rates can be compared to the general population, which is somewhere around one percent.

Some 30 years ago, civil libertarians forced a national agenda that prohibits treatment of individuals with brain disorders until they present an imminent danger to themselves or others. It was a purely ideological campaign based on the premise that the right to refuse treatment is paramount, regardless of its consequences.

As a result, state laws prevent us from treating people with severe mental illness before it is too late -- too often the inevitable consequence is suicide.

Appropriate medical intervention could prevent such senseless deaths. Advanced medications are allowing millions to reclaim full, productive lives. And, repeated scientific studies have shown that early intervention increases an individual's chances for long term recovery.

Many individuals who refuse treatment lack the capacity to make informed treatment decisions due to their illness. Approximately half of individuals with these illnesses suffer from symptoms that impair their self-awareness. They do not recognize that they are ill, and therefore refuse treatment. But, treatment can alleviate the other symptoms of these illnesses that too often lead an individual to commit suicide before we are allowed to intervene.

We urge Surgeon General Satcher to hold state governments accountable when they allow Americans with serious brain disorders to go without lifesaving treatment and to educate health care providers on the need for early intervention, especially with this vulnerable group. We applaud the Surgeon General for recognizing that the time has come to remove legal and clinical barriers to timely and humane treatment for individuals with serious brain disorders who are most at risk.

 

###

The Treatment Advocacy Center (www.treatmentadvocacycenter.org) is a national nonprofit organization dedicated to eliminating barriers to the timely and effective treatment of severe mental illnesses. TAC promotes laws, policies, and practices for the delivery of psychiatric care and supports the development of innovative treatments for and research into the causes of severe and persistent psychiatric illnesses, such as schizophrenia and bipolar disorder.

 

ADDITIONAL INFORMATION
suicide among people with severe mental illnesses | press room


general resources | legal resources | medical resources | briefing papers | state activity   
hospital closures | preventable tragedies | press room | search | home

FootnoteImage2.jpg (1088 bytes)
Treatment Advocacy Center

The contents of TAC's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated. All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made. TAC is an I.R.C. � 501(c)(3) tax-exempt corporation. Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. � 170. Please note that TAC does not accept funding from pharmaceutical companies or entities involved in the sale, marketing, or distribution of such products.

Treatment Advocacy Center (TAC), 200 N. Glebe Road, Suite 730, Arlington, VA 22203
703 294 6001/6002 (phone) | 703 294 6010 (fax) | www.treatmentadvocacycenter.org (website)
[email protected] (general email) | [email protected] (press contact)
[email protected] (webmaster)